“…These patients comprise a significant portion of AAA patients. Therefore, the hemodynamically less loading and miniinvasive EVAR, with acceptable mortality also in high operating risk patients (4.7 %), has come into focus in the last decade [12][13][14][15] . Unfortunately, EVAR has technical limitations caused by the present stent-graft system construction and the indication depends on AAA morphology.…”